
A study into the implementation and scale-up of Robot-Assisted Surgery in the NHS. Funded by @NIHRresearch, managed by @SITU_Oxford, @UniofOxford & @AberdeenUni
- Tweets62
- Following89
- Followers135
- Likes258

ALT This study aims to work out if robot-assisted surgery (RAS), a relatively new development, should be routinely available in the NHS and also assess any barriers to its implementation. Over the next 20 years, surgery performed with the help of a robot is expected to increase rapidly around the world, especially for cancer conditions. Previous research shows that when RAS has been introduced in some clinical areas, like urology, it can help surgeons be more precise and can reduce a patient’s hospital stay. Using RAS may also speed up training for surgeons to enable them to become experts more quickly. However, RAS has not been tested in all clinical areas and is very expensive with each robot costing over £ 1 million). Also, when RAS is introduced into hospitals it requires special consideration as the set-up can be disruptive. It is not yet clear whether the benefits to patients or the health system of doing surgery this way is worth the cost and the disruption.





















